Biography of Andreas Rummelt
Last update: 22 days agoCareer
Andreas was Chief Executive Officer at InterPharmaLink, and Group Head of Quality Assurance and Technical Operations at Novartis. Andreas Rummelt joined Xellia in 2010.
Andreas Rummelt is currently- Director at Xellia - View - Xellia org chart
- Member of the Supervisory Board at Leukocare - View - Leukocare org chart
- Non-Executive Director at AstraZeneca - View - AstraZeneca org chart
Create your alert
to follow the career of Andreas Rummelt.
Education
Andreas Rummelt has a PhD in Pharmaceutical Sciences from University of Erlangen-Nuremberg.
They have also studied at University of Erlangen-Nuremberg :
Find more alumni from University of Erlangen-Nuremberg
More about Andreas Rummelt
Selected links
Do you need to know more about Andreas Rummelt? More results.
Participate
Social media
- Andreas Rummelt on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Andreas Rummelt
The colleagues of Andreas Rummelt
Company Colleagues
- At Xellia, Andreas Rummelt has 20 colleagues including Michael Kocher (CEO), Steen Riisgaard (Chairman of the Board)…
- At Leukocare, Andreas Rummelt has 11 colleagues including Michael Scholl (CEO), Jean-Paul Prieels (Director)…
- At AstraZeneca, Andreas Rummelt has 362 colleagues including Pascal Soriot (CEO & Director), Deborah DiSanzo (Director)…
Industry Colleagues
- In the Pharmaceuticals industry, Andreas Rummelt has 19,336 colleagues in 1,864 companies located in 69 countries. 8,427 executive movements have been recorded in the last 12 months. Learn more about Pharmaceuticals.
Report an error
Update the org chart details of Andreas Rummelt.
Get in Touch
and ask for Andreas Rummelt.
